Akashi Therapeutics, Inc.
Records under this name other than the patents Akashi Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 1 of 1 · Back to Akashi Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,383,608 | Novel Imidazolidine Compounds as Androgen Receptor Modulators Lapsed on the fee record Ended Feb 26, 2025 · High confidence | Lapsed on the fee record | Ended Feb 26, 2025 | High confidence |